Markets rejoice at the Q1 beat; guidance upgraded
14/05/24 -"Q1 profitability surpassed the consensus’ estimates. The top-line performance was supported by both segments and the ‘core’ operating margin was higher than the annual guidance. The management ..."
Pages
53
Language
English
Published on
14/05/24
You may also be interested by these reports :
20/08/26
GN reported a weak quarter, impacted by challenging market conditions and subdued consumer sentiment. The decline in the top line was primarily ...
19/08/26
S&N Q2/H1 26 print disappointed: revenue missed consensus, forcing management to cut FY26 revenue growth guidance to 4% from 6%, while Orthopaedics ...
19/08/26
With the release of the 1H results, we have slightly adjusted our expectations. We account for no revenue from pre-approved services in 2026, and ...
18/08/26
Coloplast delivered a mixed Q3 FY26: revenue beat consensus (+1.2%) but EBIT missed (-1%), with the margin declining for a third straight quarter. ...